News

ABLE member Strand Life Sciences presents “Report on Genomic Surveillance of SARS-CoV-2” in the city of Bengaluru

ABLE Member Strand Life Sciences presented insights from its COVID19 genomic surveillance initiative of sequencing 12,800 SARS-CoV-2 samples

Jul 17, 2022

By : ABLE

StringBio raises $20 million in Series B funding round

String Bio announced the first closure of its Series B round after raising $20 million (around Rs 156 crore), led by Woodside Energy, with participation from Ankur Capital, Dare Ventures, Redstart and Zenfold Ventures, among other investors.

Jul 11, 2022

By : ABLE

Karnataka: Science and technology minister lays foundation for anti-venom research centre in Bengaluru

The centre would be built at a cost of Rs 7 crore, officials said. It will come up on a total built-up area of about 16,000 sqft.

Jul 06, 2022

By : Team ABLE

Tamil Nadu releases policies on R&D and Life Sciences Promotion

Chief Minister MK Stalin released the policies at the Tamil Nadu Investors' First Port of Call-Investment Conclave held on Monday.

Jul 04, 2022

By : ABLE

Biocom California sees India on life sciences radar with its manufacturing prowess and scientific acumen

Joseph Panetta, president & CEO, Biocom California said, “It is India’s infrastructure for manufacture of biologics, biosimilars, qualified pool of scientific human resources and strong intellectual property rights’ (IPR) adherence that have been the three top attractive factors for us to be here and scout for potential opportunities in collaborations. Therefore, we are here to understand the industry, market prospects and engage in discussions with Indian biotech companies.

Jun 23, 2022

By : Team ABLE